Association between the IL13 rs1800925 (-1112C/T) polymorphism and Schistosoma mansoni infection intensity in a population from western Côte d’Ivoire
Paper Details
Association between the IL13 rs1800925 (-1112C/T) polymorphism and Schistosoma mansoni infection intensity in a population from western Côte d’Ivoire
Abstract
Intestinal schistosomiasis remains a major public health concern in sub-Saharan Africa. Interindividual variation in infection intensity suggests that host genetic factors, particularly the IL13 rs1800925 (-1112C/T) polymorphism, may influence the Th2 immune response to Schistosoma mansoni. This study aimed to investigate the association of this polymorphism with susceptibility to S. mansoni infection and infection intensity in a population from western Côte d’Ivoire. A case-control study was conducted among individuals living in an endemic area. Genotyping of the IL13 −1112C/T (rs1800925) polymorphism was performed using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Associations between the polymorphism and both susceptibility to infection and infection intensity were assessed using logistic regression analysis. No significant association was observed between the IL13 rs1800925 polymorphism and susceptibility to S. mansoni infection. However, the CT genotype and carriage of the T allele were significantly associated with a reduced risk of high-intensity infection. In addition, children younger than 15 years were at a significantly higher risk of developing heavy-intensity infections. The IL13 rs1800925 polymorphism does not appear to influence susceptibility to S. mansoni infection but may contribute to the regulation of parasite burden. These findings highlight the importance of host immunogenetic factors in modulating infection intensity and warrant further large-scale functional studies to clarify the role of this polymorphism in the immune response to intestinal schistosomiasis.
Abdel Aziz N, Musaigwa F, Mosala P, Berkiks I, Brombacher F. 2022. Type 2 immunity: A two-edged sword in schistosomiasis immunopathology. Trends in Immunology 43(8), 657–673. DOI: 10.1016/j.it.2022.06.005
Alemu G, Nibret E. 2024. Evaluation of the urine POC-CCA test accuracy in the detection of Schistosoma mansoni infection: A systematic review and meta-analysis. Journal of Tropical Medicine 2024, 5531687. DOI: 10.1155/2024/5531687
Assaré RK, Bassa FK, Coulibaly JT, Diakité NR, Ouattara M, N’Goran EK, Utzinger J. 2026. Prevalence, risk factors and trends of human schistosomiasis in Côte d’Ivoire from 1974–2023: Systematic review and meta-analysis. Infectious Diseases of Poverty 15, 8. DOI: 10.1186/s40249-025-01410-9
Ayabina DV, Clark J, Bayley H, Lamberton PHL, Toor J, Hollingsworth TD. 2021. Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis. PLoS Neglected Tropical Diseases 15(11), e0009083. DOI: 10.1371/journal.pntd.0009083
Chanhanga N, Mindu T, Mogaka J, Chimbari M. 2023. The impact of targeted treatment and mass drug administration delivery strategies on the prevalence and intensity of schistosomiasis in school aged children in Africa: A systematic review. Infection and Drug Resistance 16, 2453–2466. DOI: 10.2147/IDR.S395382
Choto ET, Mduluza T, Chimbari MJ. 2021. Interleukin-13 rs1800925/-1112C/T promoter single nucleotide polymorphism variant linked to anti-schistosomiasis in adult males in Murehwa District, Zimbabwe. PLoS ONE 16(5), e0252220. DOI: 10.1371/journal.pone.0252220
Drurey C, Lindholm HT, Coakley G, Poveda MC, Löser S, Doolan R, Gerbe F, Jay P, Harris N, Oudhoff MJ, Maizels RM. 2021. Intestinal epithelial tuft cell induction is negated by a murine helminth and its secreted products. Journal of Experimental Medicine 219(1), e20211140. DOI: 10.1084/jem.20211140
Fofana B, Takala-Harrison S, Ouattara A, Djimdé A. 2023. Human genetic factors as determinants of resistance to malaria: A systematic review. AJPME 1(1). DOI: 10.35995/ajpme1010006
Gaceja KV, Ancheta ZFR, Buna ACA, Clarencio SMS, Garrido MAR, Ramos JDA. 2023. Association of interleukin-13 gene single nucleotide polymorphism rs1800925 with allergic asthma in Asian population: A meta-analysis. Asia Pacific Allergy 13(4), 148–157. DOI: 10.5415/apallergy.0000000000000119
Hong S-T. 2023. Review of recent prevalence of urogenital schistosomiasis in Sub-Saharan Africa and diagnostic challenges in the field setting. Life 13(8), 1670. DOI: 10.3390/life13081670
Junior J Do ES, De Souza JL, da Silva LS, da Silva CC, do Nascimento TA, de Souza MLG, da Cunha AF, Batista J da S, Neto JP de M, Guerra MV de F, Ramasawmy R. 2023. A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13. Frontiers in Immunology 14, 1232488. DOI: 10.3389/fimmu.2023.1232488
Lekki-Jóźwiak J, Bąska P. 2024. The roles of various immune cell populations in immune response against helminths. International Journal of Molecular Sciences 25(1), 420. DOI: 10.3390/ijms25010420
Lo NC, Bezerra FSM, Colley DG, Fleming FM, Homeida M, Kabatereine N, Kabole FM, King CH, Mafe MA, Midzi N, Mutapi F, Mwanga JR, Ramzy RMR, Satrija F, Stothard JR, Traoré MS, Webster JP, Utzinger J, Zhou X-N. 2022. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. The Lancet Infectious Diseases 22(11), e327–e335. DOI: 10.1016/S1473-3099(22)00221-3
Maizels RM, Gause WC. 2023. Targeting helminths: The expanding world of type 2 immune effector mechanisms. Journal of Experimental Medicine 220(10), e20221381. DOI: 10.1084/jem.20221381
Mewamba EM, Noyes H, Tiofack AAZ, Kamga RMN, Kamdem CN, Mengoue LET, Ofon E, Ngassam RIK, Nyangiri O, Bucheton B, Njiokou F, Womeni MH, Matovu E, MacLeod A, Simo G. 2023. Association between polymorphisms of IL4, IL13, IL10, STAT6 and IFNG genes, cytokines and immunoglobulin E levels with high burden of Schistosoma mansoni in children from schistosomiasis endemic areas of Cameroon. Infection, Genetics and Evolution 111, 105416. DOI: 10.1016/j.meegid.2023.105416
Oyesola OO, Souza COS, Loke P. 2022. The influence of genetic and environmental factors and their interactions on immune response to helminth infections. Frontiers in Immunology 13. DOI: 10.3389/fimmu.2022.869163
Reitzug F, Ledien J, Chami GF. 2023. Associations of water contact frequency, duration, and activities with schistosome infection risk: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases 17(6), e0011377. DOI: 10.1371/journal.pntd.0011377
Sékré J-BK, Diakité NR, Assaré RK, Kouadio JN, Coulibaly G, Konan CK, Kouamin A-C, Méité A, Hattendorf J, Ouattara M, Utzinger J, N’Goran EK. 2024. Potential associations between Schistosoma mansoni infection and physico-chemical characteristics and water-related human activities in Côte d’Ivoire: A cross-sectional study. Parasites and Vectors 17(1), 422. DOI: 10.1186/s13071-024-06466-4
Sokouri EA, Ahouty Ahouty B, N’Djetchi M, Abé IA, Yao BGFD, Konan TK, MacLeod A, Noyes H, Nyangiri O, Matovu E, Koffi M, TrypanoGEN+ Research Group of the H3Africa Consortium. 2024a. Impact of environmental factors on Biomphalaria pfeifferi vector capacity leading to human infection by Schistosoma mansoni in two regions of western Côte d’Ivoire. Parasites and Vectors 17(1), 179. DOI: 10.1186/s13071-024-06163-2
Sokouri EA, Ahouty B, Abé IA, Yao FGD, Konan TK, Nyangiri OA, MacLeod A, Matovu E, Noyes H, Koffi M, TrypanoGEN+ Research Group of the H3Africa Consortium. 2024b. Evaluation of the epidemiological situation of intestinal schistosomiasis using the POC-CCA parasite antigen test and the Kato-Katz egg count test in school-age children in endemic villages in western Côte d’Ivoire. Parasite 31, 66. DOI: 10.1051/parasite/2024049
Tavakoli Pirzaman A, Sepidarkish M, Alizadeh F, Al-Obidy S, Ebrahimi P, Kianifard N, Sheikhi Nooshabadi M, Jafari Tadi M, Zolfaghari Dehkharghani M, Mousavi S, Rezapour N, Mohammadnia S, Fazlollahpour Naghibi A, Bagheri K, Asghari M-H, Bayani M, Rollinson D, Gasser RB, Rostami A. 2024. Prevalence of human Schistosoma mansoni infection in endemic regions (2010–2024): A systematic review and meta-analysis. eClinicalMedicine 77, 102855. DOI: 10.1016/j.eclinm.2024.102855
Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, Lamberton PHL. 2022. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasites and Vectors 15(1), 15. DOI: 10.1186/s13071-021-05121-6
WHO. 2022. WHO guideline on control and elimination of human schistosomiasis. Retrieved from https://www.who.int/publications/i/item/9789240041608
WHO. 2023. Lignes directrices de l’OMS sur la lutte et l’élimination de la schistosomiase humaine: Recommandations fondées sur des preuves. Retrieved from https://www.who.int/fr/publications/i/item/9789240041608
Ye C, Zhang L, Tang L, Duan Y, Liu J, Zhou H. 2023. Host genetic backgrounds: The key to determining parasite-host adaptation. Frontiers in Cellular and Infection Microbiology 13. DOI: 10.3389/fcimb.2023.1228206
Bernardin Ahouty Ahouty*, Abla Edwige Sokouri, Georges Bohoussou Kassi, Innocent Allépo Abé, Martial Kassi N’djetchi, Yaya Ouangbo Ouattara, Ornella Karmelle Lydia Dago, Mathurin Yao Koffi, Thomas Konan Konan, Mathurin N’Goran Koffi, 2026. Association between the IL13 rs1800925 (-1112C/T) polymorphism and Schistosoma mansoni infection intensity in a population from western Côte d’Ivoire. Int. J. Biosci., 29(3), 20-31.
Copyright © 2026 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.